Jorgensen Nathan D. 4
4 · Vor Biopharma Inc. · Filed Mar 2, 2023
Insider Transaction Report
Form 4
Jorgensen Nathan D.
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2023-03-01$5.51/sh−6,310$34,768→ 154,459 total
Footnotes (1)
- [F1]Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units ("RSUs").